Leukemia

Top Story

CAR T-cell therapy pioneer among Time magazine’s 100 most influential people

CAR T-cell therapy pioneer among <i>Time</i> magazine’s 100 most influential people
April 23, 2018

Columbia University professor joins Samuel Waxman Cancer Research Foundation advisory board

April 10, 2018
Adolfo Ferrando, MD, PhD, has joined Samuel Waxman Cancer Research Foundation’s scientific advisory board. Ferrando is professor at Institute for Cancer Genetics…
FDA News

FDA grants priority review to duvelisib for leukemia, lymphoma subtypes

April 9, 2018
The FDA granted priority review to duvelisib for the treatment of relapsed or refractory chronic lymphocytic leukemia, small lymphocytic lymphoma and follicular…
FDA News

FDA declines proposed Rituxan, Herceptin biosimilars from Celltrion

April 6, 2018
The FDA has rejected approval of Celltrion’s biologics license applications for Truxima, a proposed rituximab biosimilar, and Herzuma, a proposed trastuzumab…
More Headlines »
CME

Targeted Therapies for Metastatic HCC: Multidisciplinary Perspectives on the Latest Clinical Advances

This activity is supported by an educational grant from Bayer Healthcare Pharmaceuticals, Inc.

The incidence of hepatocellular carcinoma (HCC) continues to increase in the United States. Management of patients…
More »
Video
Meeting News

VIDEO: Late health problems becoming less common in childhood cancer survivors

June 4, 2017
More »
Resource Centers
American Association for Cancer Research Annual Meeting

American Association for Cancer Research Annual Meeting

CME ABIM MOC

Ace the Case: A 48-Year-Old Woman Confused About a Diagnosis of Leukemia

There is no commercial support for this activity.

This “Ace the Case” activity will utilize a case study to discuss the assessment and management of a 48-year-old woman…
More »